Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of 9.78 billion as of July 11, 2025. Its market cap has decreased by -8.78% in one year.

Market Cap

9.78B

Enterprise Value

9.45B

Revenue

1.87B

Ranking

n/a

PE Ratio

41.34

Stock Price

128.20

Market Cap Chart

Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 136.97M to 9.78B, an increase of 7,043.81%. That is a compound annual growth rate of 15.77%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	9.78B	-11.36%
Dec 31, 2024	11.04B	8.62%
Dec 29, 2023	10.16B	6.65%
Dec 30, 2022	9.53B	59.70%
Dec 31, 2021	5.97B	-9.03%
Dec 31, 2020	6.56B	-12.24%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	162.05B
GSK plc	56.99B
Haleon	33.01B
Smith & Nephew	9.82B
ConvaTec Group	5.33B
Hikma Pharmaceuticals	4.32B
HUTCHMED (China)	2.02B
Genus	1.46B

Market Cap Rankings